Clinical Trial Update: Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the impact on xerostomia in nasopharyngeal carcinoma patients treated with or without superficial parotid lobe-sparing IMRT; c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma
• Radiation-induced Xerostomia

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma, Radiation-induced Xerostomia | Phase 2 | Status: COMPLETED